Dialyzable drugs: Difference between revisions
Ostermayer (talk | contribs) No edit summary |
Ostermayer (talk | contribs) |
||
Line 32: | Line 32: | ||
==See Also== | ==See Also== | ||
[[ | [[Complete dialyzable drugs chart]] | ||
[[Category:Tox]] | [[Category:Tox]] |
Revision as of 03:52, 6 December 2015
Background
The ability to successfully dialyze a drug depends on: molecular size, protein binding, volume of distribution, and plasma clearance.
Molecular weight
smaller molecular weight substances will pass through the dialysis membrane more easily than larger molecular weights.
Protein Binding
Drugs with a high degree of protein binding will have a small plasma concentration of unbound drug available for dialysis, making them poorly dialyzable or requiring multiple sessions.
Volume of Distribution
Drugs with large volumes of distribution usually due to lipid solubility and low plasma protein binding are poorly diliazable.
Plasma clearance
Although plasma clearance may be beneficial, increasing plasma clearance will dcrease dialysis clearance.
Dialysis Flow Rates
Greater degrees of dialysis can be achieved with faster dialysate flow rates if the dialysate drug concentrations is low. As the concentration of drug is increased in the diasylate the flow rate needs to be lowered.
Common Dialyzable Drugs
B - Barbiturates
L - Lithium
I - Isoniazid
S - Salicylates
T - Theophyline/Caffeine (both are methylxanthines)
M - Methanol
E - Ethylene glycol
D - Depakote
Others - Carbamezepine